v3.26.3
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Millions
 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Cash Flows from Operating Activities:    
Net earnings $ 915 $ 141
Adjustments to reconcile net earnings (loss) to net cash provided by operating activities:    
Depreciation and amortization 539 491
(Gain) loss on sales of investments and other assets and asset impairments, net 267 176
(Gain) on sale of F&G Life Re (7) 0
Interest credited/index credits to contractholder account balances 871 337
Change in market risk benefits, net (62) 148
Deferred policy acquisition costs and deferred sales inducements (922) (956)
Charges assessed to contractholders for mortality and administration (344) (248)
Distributions from unconsolidated affiliates, return on investment 124 120
Stock-based compensation cost 26 22
Change in NAV of limited partnerships, net (292) (231)
Change in valuation of derivatives, equity and preferred securities and other assets, net (601) (179)
Changes in assets and liabilities, net of effects from acquisitions:    
Change in reinsurance recoverable 92 3
Change in derivative collateral (370) 144
Change in future policy benefits 292 978
Change in funds withheld from reinsurers 2,558 2,648
Net change in income taxes 254 (21)
Net change in other assets and other liabilities (128) (60)
Net cash provided by operating activities 3,212 3,513
Cash Flows from Investing Activities:    
Proceeds from sales, calls and maturities of investments 14,690 9,592
Additions to property and equipment and capitalized software (7) (12)
Purchases of investment securities (16,908) (16,070)
Net proceeds from sales, maturities and purchases of short-term investment securities 325 1,653
Other acquisitions/disposals, net of cash acquired 88 0
Additional investments in unconsolidated affiliates (820) (1,597)
Net increase in policy loans (39) (32)
Distributions from unconsolidated affiliates, return of investment 507 330
Net change in notes receivable (13) (6)
Net cash used in investing activities (2,177) (6,142)
Cash Flows from Financing Activities:    
Borrowings 0 375
Debt issuance costs 0 (11)
Payment of contingent consideration for acquisitions (7) (10)
Repayments of outstanding debt 0 (300)
Dividends paid (112) (98)
Dividends and distributions paid to non-controlling interest shareholders (12) (13)
Purchases of treasury stock (123) (3)
Issuance of common stock 0 269
Contractholder account deposits 5,885 8,991
Contractholder account withdrawals (6,592) (6,646)
Net cash (used in) provided by financing activities (961) 2,554
Net increase (decrease) in cash and cash equivalents 74 (75)
Cash and cash equivalents at beginning of period 1,486 2,264
Cash and cash equivalents at end of period $ 1,560 $ 2,189